Charles Johannes

President @Peptide Drug Hunting Consortium

Cambridge, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2026 — Present

President @Peptide Drug Hunting Consortium

View department →

As President of PDHC, I steward the strategic direction and scientific standards of a global nonprofit advancing peptide and macrocyclic drug discovery. I oversee programming architecture, sponsor governance frameworks, and cross-sector collaboration to ensure rigor, technical depth, and translational relevance across the peptide therapeutics ecosystem.

EDUCATION

1989 — 1993

Guilford College

BS, Chemistry

1993 — 1998

Boston College

Ph.D., Organic Chemistry

ABOUT CHARLES JOHANNES

Discovery chemistry leader and strategic advisor specializing in peptide therapeutics, targeted protein degraders, natural products, and small molecule drug discovery. Expert in translating scientific innovation into executable discovery strategies that integrate chemistry, biology, and AI-enabled design.As Founder & Principal of EPOC Scientific LLC, I advise biotech companies and investors on modality strategy, discovery architecture, CRO execution models, and portfolio decision frameworks.I serve as President of the Peptide Drug Hunting Consortium (PDHC), advancing rigorous, data-driven programming and cross-sector collaboration within the peptide drug discovery ecosystem.My focus is building and strengthening discovery organizations capable of delivering durable therapeutic innovation.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Charles Johannes — President at Peptide Drug Hunting Consortium in Cambridge, MA, US | Unifers